Specialist Advisory Services for the BRITE Biologics Innovation and Manufacturing Ecosystem

This tender presents a clear project description but suffers from significant deficiencies in evaluation criteria, financial requirements, and estimated value disclosure, which undermines transparency and fairness.

The procedure type and CPV code are clear, and there are no disputes. However, the missing tender reveal date, classified value, and lack of specific mandatory exclusion grounds are compliance weaknesses, particularly for an open competition.

The project description and technical requirements are clear and well-defined. However, the critical absence of specified evaluation criteria, along with missing financial requirements and exclusion grounds, significantly reduces the overall clarity of the tender process.

Basic information, key dates, and documents are present. Nevertheless, the tender is incomplete due to the undisclosed estimated value, the lack of defined evaluation criteria, and the absence of specific financial and mandatory exclusion requirements.

The classified value and, most critically, the complete absence of evaluation criteria severely compromise the transparency and objectivity of the tender, hindering fair competition among potential bidders.

Electronic submission via the Delta eSourcing portal is supported, and key dates (contract start, duration) are clearly specified. However, the undisclosed estimated value and lack of specific financial requirements make it less practical for bidders to prepare informed and competitive proposals.

The core data fields are largely consistent and logical, with dates flowing correctly and no disputes. Minor inconsistencies include empty fields for 'Liable Person' and procedure codes.

While the project's subject matter (biologics innovation) is inherently innovative, the tender documentation itself does not explicitly incorporate green procurement or social responsibility criteria into the procurement process.